Following a workshop in February around Clinical Development of Novel Drug-Radiotherapy Combinations, a paper has been published on these novel approaches @AACR#RxRTCombos18 https://t.co/b9MEmGLJTq
ICYMI: We're taking steps to accelerate research in radiation biology and radio-oncology, following an independent review of support for this field. Find out more: https://t.co/v6rNV2Ru5C
With our @USUKFulbright Award, you could spend a year in the US developing your research. Open now for a second round of funding, deadline 6 November: https://t.co/pfbox0NuqJ
Not sure where to start when translating your research for patient benefit? Come to our first free Innovation Summit - on the theme of commercialisation for clinical impact - on November 19 to meet and hear from our experts: https://t.co/oJCtNnb9hN
At the launch event for the integrated Liverpool head and neck centre: principles built on world-class research, innovation and patient care. Wonderful development for head and neck cancer
Our first submission to @ChemRxiv is collaborative work with @Hammond_Lab carried out by @collinus. We have made bioreductive prodrugs of IPTG, placing the expression of GFP (or any other protein) under the control of hypoxia. A kind of artificial HIF system if you like. https://t.co/bsyoGe4brJ
Practice changing trials in radiation oncology - a @NCRI_CTRad initiative - - the next challenge is to achieve this for proton beam and mri guided radiotherapy. Open access paper to download - led by Charlotte Coles and Marieke Thompson @ProfAJChalmers @finn_corinne
Tumor biopsies collected for research often don't have enough of the tumor tissue (green blocks). A new study aims to change that: https://t.co/hpliPF4vUf @NCItreatment